Industries > Pharma > Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2020-2030

Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2020-2030

Forecasts by Product Type (Monoclonal Antibodies, Insulin, Cytokines, Vaccines, Blood Factors, Others), Application (Cancer, Diabetes, Cardiovascular Diseases, CNS, Infectious, Others), Molecule (Small Molecule and Large Molecule), Container (Bottles, Ampoules, Vials, Bags, Pre-filled Syringes, Others) Plus Company Profiling of Major Players in the CMO of Sterile Injectable Drugs field

PUBLISHED: 01 May 2020
PAGES: 161
PRODUCT CODE: PHA0737
SUBMARKET: Contract Services

Clear
WOOCS 2.2.1

Our 161-page report provides 77 tables, 75 charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing CMO of sterile injectable drugs market. See how to exploit the opportunities.

Forecasts to 2030 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), Porter’s Five Forces Analysis, product profiles and commercial developments.

Discover sales predictions for the global market and submarkets
Along with revenue prediction for the overall world market, there are 4 segmentations of the CMO of sterile injectable drugs market, with forecasts for 5 product types, 6 applications, 2 molecules, 5 containers each forecasted at a global and regional level.

Global CMO of Sterile Injectable Drugs Market by Product Type
• Monoclonal antibodies
• Insulin
• Cytokines
• Vaccines
• Blood factors
• Others

Global CMO of Sterile Injectable Drugs Market by Application
• Cancer
• Diabetes
• Cardiovascular diseases
• CNS
• Infectious
• Others

Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2020-2030

Global CMO of Sterile Injectable Drugs Market by Molecule
• Large Molecule
• Small Molecule

Global CMO of Sterile Injectable Drugs Market by Container
• Bottles
• Ampoules
• Vials
• Prefilled syringes
• Bags

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 18 leading national markets:

• North America:
• US
• Canada

• Europe:
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe

• Asia-Pacific:
• Japan
• China
• India
• Rest of Asia-Pacific

• Latin America

• Middle East & Africa

Leading Companies covered in the report include:
• Jubilant Life Sciences Limited
• Boehringer Ingelheim
• Pfizer CentreOne
• Baxter Biopharma Solutions
• Recipharm AB
• Lonza
• Famar Health Care Services
• Patheon, Inc (Parent organization: Thermo Fischer company)
• Catalent, Inc
• Almac Group
• Evonik Industries AG
• Siegfried Holding AG
• Consort Medical, Plc.
• Aenova Group
• Grifols SA

The report also includes profiles and for some of the leading companies in the CMO of sterile injectable drugs market, with a focus on this segment of these companies’ operations:
• Famar Health Care Services
• Boehringer Ingelheim
• Baxter Biopharma Solutions
• Lonza
• Jubilant Life Sciences Limited

There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, U.S., UK, Germany, Japan, India and China in particular, will continue to achieve high revenue growth to 2030.

Leading companies and the potential for market growth
Overall world revenue for CMO of sterile injectable drugs will surpass US$55.33 billion by 2030, our work calculates. We predict strong revenue growth through to 2030. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the CMO of Sterile Injectable Drugs Market report helps you
In summary, our 160 pages report provides you with the following knowledge:
• Revenue forecasts to 2030 for 4 segmentations of the CMO of Sterile Injectable Drugs market, with forecasts for 5 product types, 6 applications, 2 molecules, 5 containers, each forecasted at a global and regional level–discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2030 for 5 regional and 11 key national markets – See forecasts for the CMO of Sterile Injectable Drugs market in North America, Latin America, Europe, Asia-Pacific and Middle East & Africa. Also forecasted is the market in the US, Canada, Germany, France, UK, Italy, Spain, China, India, and Japan.
• Drivers, Restraints, Challenges, Opportunities
• Porter’s Five Forces Analysis
• Prospects for established firms and those seeking to enter the market– including company profiles for 15 of the major companies involved in the CMO of sterile injectable drugs market
• Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain study is for everybody needing commercial analyses for the CMO of Sterile Injectable Drugs market and leading companies. You will find data, trends and predictions.

Get our report today (CMO) of Sterile Injectable Drugs Market : Forecasts by Product Type (Monoclonal Antibodies, Insulin, Cytokines, Vaccines, Blood Factors, Others), Application (Cancer, Diabetes, Cardiovascular Diseases, CNS, Infectious, Others), Molecule (Small Molecule and Large Molecule), Container (Bottles, Ampoules, Vials, Bags, Pre-filled Syringes, Others) Plus Company Profiling of Major Players.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2020-2030


Latest Pharma news

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021

READ

Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.

07 October 2021

READ

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031

Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.

06 October 2021

READ

Visiongain Publishes Meningococcal Vaccines Market Report 2021-2031

Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market

05 October 2021

READ

Categories